Michael Nofi
Patrimonio netto: - $ in data 31/08/2026
Patrimonio netto: - $ in data 31/08/2026
Michael P.
Nofi is currently Chief Financial Officer at Parlux Fragrances LLC and will be Chief Financial Officer at Edgewise Therapeutics, Inc. starting in 2025.
Formerly, Mr. Nofi was Chief Financial Officer at Perfumania Holdings, Inc. from 2017 to 2018 and Chief Accounting Officer at Springworks Therapeutics, Inc. from 2019 to 2025.
Mr. Nofi completed undergraduate studies at Villanova University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 10/11/2025 |
Parlux Fragrances LLC
Parlux Fragrances LLC Household/Personal CareConsumer Non-Durables Manufactures a broad line of toiletries, perfumes and colognes | Direttore Finanziario/CFO | - |
| Società | Posizione | Fine |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/07/2025 |
| PERFUMANIA HOLDINGS, INC. | Direttore Finanziario/CFO | 01/10/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Parlux Fragrances LLC
Parlux Fragrances LLC Household/Personal CareConsumer Non-Durables Manufactures a broad line of toiletries, perfumes and colognes | Consumer Non-Durables |
Perfumania Holdings, Inc.
Perfumania Holdings, Inc. Specialty StoresRetail Trade Retails and distributes perfumes & fragrances | Retail Trade |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Springworks Therapeutics, Inc.
Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale